Sequence Similarity Clusters for the Entities in PDB 1I8K

Entity #1 | Chains: A
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN protein, length: 107 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 35793
95 % 1 2 30530 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 1 2 29280
70 % 1 2 26307
50 % 45 317 23
40 % 51 361 27
30 % 687 7175 1
Entity #2 | Chains: B
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN protein, length: 124 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 35792
95 % 1 2 30529 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 1 2 29279
70 % 86 409 9
50 % 106 609 6
40 % 564 5756 1
30 % 688 7175 1
Entity #3 | Chains: C
EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII PEPTIDE ANTIGEN protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 5IVN 1 A BC2-nanobody 30538
2 5E7B 1 A nanobody nano-L06 9838
3 2P45 2 B ANTIBODY CAB-RN05 9838
4 2X1Q 1 A, B GELSOLIN NANOBODY 9844
5 5U64 1 B VHH-28 9838
6 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
7 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
8 4B41 1 A, B ANTIBODY G7 9844
9 5IMM 1 B Nanobody 9835
10 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
11 5NLU 1 A single domain llama antibody Nb36 9844
12 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
13 5IMK 1 B Nanobody 9835
14 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
15 4B50 1 A 2H10 LLAMA VHH 9844
16 2XT1 2 B CAMELID VHH 9 30538
17 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
18 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
19 5J1S 3 C VHH domain BS-2 30538
20 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
21 5J1T 3 C VHH domain BS-2 30538
22 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
23 2X1O 1 A, B GELSOLIN NANOBODY 9844
24 4QGY 1 A, B nanobody n25, VH domain 9844
25 5C2B 1 H scFv 3B4 heavy chain 9606
26 5VNV 1 A Nb.b201 32630
27 5DXW 1 A PD-L1 nanobody 10090
28 4N9O 2 B Nanobody Nb484 Nb484 9844
29 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
30 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
31 1T2J 1 A M12-Variable Heavy domain 9606
32 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
33 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
34 5VM6 1 A single domain camelid nanobody VHH T10 9844
35 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
36 4KML 2 B Nanobody 9844
37 4Z9K 2 B VHH2(F5) antibody 30538
38 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
39 5LMW 1 A Nanobody 9844
40 5NM0 1 A, B, C, D Nb36 9844
41 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
42 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
43 4PPT 1 A Engineered single domain VHH antibody 9844
44 3R0M 1 A, B Llama VHH A12 9844
45 3ZKQ 2 D XA4813 9844
46 4I13 2 B Protein ca1697 (nanobody) 9844
47 5C2U 1 B Nanobody Nanobody 9838
48 1XFP 1 A heavy chain antibody VHH domain 9838
49 4POY 1 A VHH-metal 9844
50 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
51 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
52 5NLW 1 A nanobody Nb36 9844
53 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
54 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
55 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
56 3G9A 2 B Minimizer 9838
57 2P43 2 B ANTIBODY CAB-RN05 9838
58 4KRN 1 A Nanobody/VHH domain EgA1 9844
59 4GFT 2 B Nanobody 9844
60 4TVS 2 a, b VHH Domain BS-1 30538
61 4W6Y 2 B Nanobody NbFedF9 9844
62 6EZW 1 B VHH antibody BCD090-M2 9844
63 1UAC 2 H Ig VH,anti-lysozyme 10090
64 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
65 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
66 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
67 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
68 5O02 2 C Nanobody (VHH) Nano-4 30538
69 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
70 4X7F 2 C, D Nano-25 Nanobody 30538
71 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
72 4LGR 2 B Camelid nanobody (VHH3) 30538
73 5J57 2 B VHH single chain antibody V5E1 30538
74 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
75 5OMM 2 C Nanobody (VHH) Nano-14 30538
76 5E03 1 A mouse CTLA-4 nanobody 10090
77 5LZ0 1 A, B PorM nanobody 9844
78 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
79 2XXC 1 B CAMELID VHH 9 30538
80 3QYC 1 A, B VH domain of IgG molecule 9606
81 5VAK 2 B Nb914 Nanobody 9844
82 2XXM 2 B CAMELID VHH 9 30538
83 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
84 5JDS 1 B Nanobody 9835
85 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
86 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
87 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
88 5L21 2 B VHH-C2 30538
89 5FWO 1 A NANOBODY 9844
90 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
91 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
92 3B9V 1 A, B, C, D heavy chain variable domain 9606
93 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
94 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
95 5N88 1 A, H VH59 antibody 9606
96 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
97 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
98 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
99 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
100 4POU 2 B VHH Antibody 9844
101 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
102 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
103 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
104 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
105 2P42 2 B, D ANTIBODY CAB-RN05 9838
106 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
107 4QLR 1 A, B Llama nanobody n02 VH domain 9844
108 5J56 2 B VHH single chain antibody V1C7 30538
109 4NBX 2 B A20.1 VHH 9844
110 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
111 4HEP 2 G vHH17 domain 9844
112 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
113 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
114 5IML 2 B Nanobody 9835
115 3A6C 2 H IG VH, anti-lysozyme 10090
116 2DQD 2 H Ig VH,anti-lysozyme 10090
117 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
118 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
119 3A67 2 H IG VH, anti-lysozyme 10090
120 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
121 1J1X 2 H Ig VH,anti-lysozyme 10090
122 5M2J 2 D Anti-(ED-B) scFV 9606
123 2DQC 2 H Ig VH,anti-lysozyme 10090
124 1J1O 2 H Ig VH,anti-lysozyme 10090
125 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
126 4M62 2 H, I GEP2 FV heavy chain 9606
127 5IVO 1 A BC2-nanobody 30538
128 1J1P 2 H Ig VH,anti-lysozyme 10090
129 4NBZ 2 B, D A26.8 VHH 9844
130 5AYU 2 H Ig VH,anti-lysozyme 10090
131 3A6B 2 H IG VH, anti-lysozyme 10090
132 2DQJ 2 H Ig VH,anti-lysozyme 10090
133 5F21 2 B nanobody MU375 9844
134 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
135 2P44 2 B ANTIBODY CAB-RN05 9838
136 1KIQ 2 B MONOCLONAL ANTIBODY D1.3 10090
137 5TP3 1 A, B F-VHH-4 9844
138 5E0Q 1 A Anti-Nup98 Nanobody TP377 30538
139 4LHJ 2 B Camelid antibody 30538
140 4BEL 2 D, E XA4813 9844
141 5M7Q 1 A, B Nanobody NbD2 9838
142 5H8D 1 A VHH nanobody 9844
143 3LN9 1 A Immunoglobulin heavy chain antibody variable domain B10 9835
144 5IP4 1 A, B XA4551 NANOBODY AGAINST C-DCX 9844
145 3DUR 2 B, D Ig-like protein 10090
146 2XV6 2 B, D CAMELID VHH 9 30538
147 4QO1 1 A Nb139 Nanobody against the DNA-binding domain of p53 9844
148 5VM0 1 A, B Camelid Nanobody VHH T9 9844
149 4ZG1 1 A, B, C, D, E, F NB17 9844
150 4I1N 2 B Protein ca1697 (nanobody) 9844
151 3QXW 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
152 6F0D 1 A, B VHH antibody BCD090-M2 9844
153 1FGV 2 H H52 FV (HEAVY CHAIN) 9606
154 4LCI 2 H anti canine CD28 antibody, 1C6, heavy chain 10090
155 4W6X 2 B Nanobody NbFedF7 9844
156 5JA9 2 A, B Nanobody 6 9844
157 1A7N 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
158 1JTP 1 A, B Single-Domain Antibody VH DOMAIN FRAGMENT 9838
159 1OP9 1 A HL6 camel VHH fragment 9838
160 2P4A 2 B, D ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
161 4LRN 1 H GEP 1 heavy chain 9606
162 4S11 1 A GELSOLIN NANOBODY 9844
163 4WEN 2 B Anti-F4+ETEC bacteria VHH variable region 9844
164 2YC1 1 A, D SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN 9606
165 5HGG 2 S, T Camelid Derived Antibody Fragment, Nb4 30538
166 6APQ 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
167 1SHM 1 A, B, D, E ANTIBODY RIG RIG VHH 9844
168 1G7H 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
169 4Y7M 1 A, B Hi113 protein 9844
170 5JMO 2 C, D camelid VHH fragment 9838
171 1A7O 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
172 1KIR 2 B MONOCLONAL ANTIBODY D1.3 10090
173 4B5E 1 A, B PS2-8 9844
174 2DQE 2 H Ig VH,anti-lysozyme 10090
175 1DVF 2 B FV D1.3 IGG1, KAPPA 10090
176 1DVF 4 D FV E5.2 IGG1, KAPPA 10090
177 1G7M 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
178 4X7C 2 C, D Nano-85 Nanobody VHH 30538
179 1OAU 1 H, I, J, K IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
180 3EBA 1 A CAbHul6 9838
181 3ZHD 1 A, B MG8-4 SCAFFOLD ANTIBODY HUMAN HEAVY CHAIN DOMAIN 9606
182 1A6W 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
183 1A7R 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
184 5VM4 1 A, B, C, D, E, F, G, H, I, J, K, L Single domain camelid nanobody VHH T10 9844
185 1WZ1 2 H Ig heavy chain Fv fragment(residues 1-123) 10090
186 4I0C 2 C, D cAbHuL5 antibody 9838
187 1A7P 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
188 1XIW 4 D, H immunoglobulin heavy chain variable region 10090
189 5NGV 2 H anti-human ActRIIB mAb BYM338 heavy-chain C-terminal His6-tag VH 9606
190 1A7Q 2 H IGG1-KAPPA D1.3 FV (HEAVY CHAIN) FV FRAGMENT 10090
191 5BOP 1 A, C Nanobody 9844
192 4DKA 1 A, B single domain antibody VHH 9844
193 5O05 1 C, D Nanobody (VHH) Nano-42 30538
194 1OHQ 1 A, B IMMUNOGLOBULIN FV FRAGMENT, RESIDUES 1-120 9606
195 1DSF 2 H ANTICANCER ANTIBODY B1 FV 10090
196 3DUU 2 B, D Ig-like protein 10090
197 3K74 2 B Nanobody 9844
198 5M15 2 C, D Synthetic nanobody L2_D09, (a-MBP#3) 32630
199 1KIP 2 B MONOCLONAL ANTIBODY D1.3 10090
200 2EIZ 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
201 1SJV 1 A r9 llama VHH single domain antibody 9844
202 4M3J 1 A, B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
203 5VL2 1 A, B, C, D, E, F, G, H T4 nanobody 9844
204 2UZI 1 H ANTI-RAS FV HEAVY CHAIN 9606
205 1UA6 2 H Ig VH,anti-lysozyme 10090
206 1IC7 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
207 4W68 1 A, B Single domain antibody 9844
208 1JTT 1 A Vh Single-Domain Antibody VH domain fragment 9838
209 1CFV 2 H MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
210 3EAK 1 A, B NbBCII10-FGLA 9838
211 1KXT 2 B, D, F IMMUNOGLOBULIN VHH FRAGMENT 9838
212 4ORZ 3 C single domain antibody sdAb19 9844
213 4UU9 1 A, H MEDI7814 VARIABLE DOMAIN HEAVY CHAIN 9606
214 6EY6 2 I, J, K, L, M, N, O, P nb130 9844
215 2VYR 2 E, F, G, H, I, J, K, L HUMAN SINGLE DOMAIN ANTIBODY 9606
216 1G7L 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
217 1BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
218 5C1M 2 B Nanobody 39 9844
219 5F7K 2 C, D Nanobody Nb-ER19 9844
220 5LMJ 1 A, B, C, D nanobody 9844
221 5E1H 2 B F8(JOB10) VHH antibody 30538
222 1F2X 1 K, L ANTIBODY HEAVY CHAIN 9838
223 4OCM 3 C, F Nb1 9844
224 5HDO 1 A, B, C, D Anti-HCV NS3/4A serine protease immoglobulin heavy chain 9838
225 1A6U 2 H B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
226 4X7E 2 C, D Nano-85 Nanobody 30538
227 5F1O 2 B nanobody MU551 9844
228 1ZV5 2 A immunoglobulin heavy chain antibody variable domain VHH D2-L29 9838
229 5O03 2 C, D Nanobody (VHH) Nano-32 11983
230 2DQI 2 H Ig VH,anti-lysozyme 10090
231 4Y8D 2 C, D nanobody 9844
232 3CX5 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
233 4EIZ 2 C, D Nb113 Camel antibody fragment 9844
234 1I3U 1 A ANTIBODY VHH LAMA DOMAIN 9844
235 1I3V 1 A, B ANTIBODY VHH LAMA DOMAIN 9844
236 4C58 2 B NANOBODY 9844
237 5B8C 2 B, E, H, K Pembrolizumab heavy chain variable region (PemVH) 9606
238 3DV6 2 B Ig-like protein 10090
239 4LAJ 3 H, I, L, M Llama single domain antibody, JM4 9844
240 2EKS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
241 5VXM 2 B Single-domain antibody 20ipaD 30538
242 4XVJ 2 H antibody heavy chain variable domain 9606
243 4IDL 1 A Single Domain Antibody VHH A9 9844
244 1JV5 2 B Ig chain heavy chain precursor V region 9606
245 1FVC 2 B, D IGG1-KAPPA 4D5 FV (HEAVY CHAIN) 9606
246 3K7U 1 A Antibody 9844
247 4Z0X 2 B Antibody HC26AM heavy chain variable domain 9606
248 1IC5 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
249 4NBY 2 B, C A20.1 VHH 9844
250 4X7D 2 C, D Nano-85 Nanobody VHH 9844
251 5VAN 2 B Nb914 Nanobody 9844
252 5F7N 2 C, D Nanobody Nb-ER19 30538
253 5OCL 1 A, C, F, H anti-llama nanobody 30538
254 5OCL 2 B, D, E, G anti-vglut nanobody 9844
255 4LAS 1 H Single heavy chain Variable fragment Heavy chain 10090
256 2A9M 2 H, I fluorescein-scfv heavy chain 9606
257 5E5M 2 B, D, F, H mouse anti CTLA-4 nanobody 10090
258 1SJX 1 A immunoglobulin VH domain 9844
259 3ZKS 2 D XA4813 9844
260 1A6V 2 H, I, J B1-8 FV (HEAVY CHAIN) FV FRAGMENT 10090
261 5MY6 2 B Nanobody 2Rs15d 9838
262 3DUS 2 B, D Ig-like protein 10090
263 5NH3 2 H, I anti-human ActRIIB mAb BYM338 Fv heavy-chain 9606
264 5M2I 2 G, H, I, J, K, L VHH1 9844
265 5MWN 2 D, E, F llama nanobody raised against TssK, nbK18 9844
266 5MWN 3 N llama nanobody raised against TssK, nbK27 9844
267 3ZHK 1 A, B MG2X1 SCAFFOLD ANTIBODY 9606
268 3K1K 2 C, D Enhancer 9838
269 4U7S 1 A, B sdAb A3 9844
270 4U3X 1 A, C Human VH domain antibody 9606
271 4W81 1 A Single Domain Antibody 9844
272 5GRV 1 L homo-specific diabody heavy chain 9606
273 5JMR 1 A, B camelid VHH fragment 9838
274 4W70 1 A Single Domain Antibody 9844
275 2GSG 2 B, D monoclonal antibody heavy chain variable domain 10090
276 5TBD 1 A, D, E, J Fv fragment (mAb4D1) heavy chain 10090
277 4BFB 2 D, E XA4813 9844
278 5DHV 1 A Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
279 5DHV 3 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
280 43C9 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
281 1NMB 3 H FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
282 5LHR 2 B Camelid-Derived Antibody Fragment Nb22 30538
283 1I8I 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
284 1OAR 1 H, I, J, K IMMUNOGLOBULIN E FV, RESIDUES 1-122 10090
285 4LHQ 2 B, D Camelid nanobody 30538
286 3DV4 2 B Ig-like protein 10090
287 3ZKX 2 B XA4813 9844
288 3ZKX 3 C XA4815 9844
289 5F1K 2 C, D nanobody MU1053 9844
290 3ZLQ 2 C, D XA4813 9844
291 1I3G 2 H ANTIBODY FV FRAGMENT VH DOMAIN 10090
292 1DL7 2 H PROTEIN (ANTIBODY M3C65 (HEAVY CHAIN)) FV (SINGLE CHAIN) 10090
293 4NC0 2 B A26.8 VHH 9844
294 1OCW 1 H IMMUNOGLOBULIN E FV REGION, RESIDUES 1-121 10090
295 1IGM 2 H IGM-KAPPA POT FV (HEAVY CHAIN) 9606
296 5GS1 2 B, N, P, R heavy chain 9606
297 5F7Y 3 C, D Nanobody Nb-ER19 9844
298 2DQG 2 H Ig VH,anti-lysozyme 10090
299 5IMO 1 B Nanobody 9835
300 5U65 1 A, B VHH-5 9838
301 4TYU 1 A, B Single Domain Antibody 9844
302 43CA 2 B, D, F, H PROTEIN (IMMUNOGLOBULIN (HEAVY CHAIN)) FV 10090
303 2DQH 2 H Ig VH,anti-lysozyme 10090
304 4AQ1 2 B, D NBKB6 VHH 9844
305 6FV0 2 F nanobody 9844
306 4EIG 2 B CA1698 camel antibody fragment 9844
307 3EHB 3 C FV fragment Chain H 10090
308 3HB3 3 C ANTIBODY FV FRAGMENT 10090
309 4FFY 2 H DENV1-E111 single chain variable fragment (heavy chain) 10090
310 2X89 1 A, B, C ANTIBODY 9838
311 5M2M 2 D, E, F, H, J, N Llama nanobody VHH3 9844
312 5O04 2 E, F Nanobody (VHH) Nano-26 30538
313 5O04 3 C, D Nanobody (VHH) Nano-85 30538
314 5LBS 2 H, I BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 ScFv fragment, heavy chain 9606
315 3P9W 2 B, D, F, H human VEGF 9606
316 1AP2 2 B, D MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
317 5F8R 2 C, D Nanobody Nb-ER19 9844
318 1IC4 2 H IGG1 FAB CHAIN H RESIDUES 1-114 10090
319 4OCL 3 C, F Nb1 9844
320 4RAV 2 A, C single-chain Fv, VH 9606
321 5XJ4 2 H durvalumab-VH 9606
322 5LWY 2 H V REGION HEAVY CHAIN 10090
323 1KB9 10 J HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
324 4X4X 1 A, C Human Variable Heavy Chain of Herceptin 9606
325 4IOS 2 D, E, F, G Llama nanobody 11 9844
326 5LHN 2 B Camelid-Derived Antibody Fragment Nb7 30538
327 2BFV 2 H FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
328 2IBZ 10 X Variable Heavy chain of antibody fragment 10090
329 4C57 2 C, D NANOBODY 9844
330 3ZHL 1 A MG8-14 SCAFFOLD ANTIBODY 9606
331 4OCN 3 C, F Nb1 9844
332 4GRW 3 E, G Nanobody 124C4 9844
333 4GRW 4 F, J Nanobody 37D5 9844
334 4GRW 5 H, I Nanobody 22E11 9844
335 5G5R 2 B NANOBODY NB330 SELECTED FROM LLAMA GLAMA 9844
336 4NC2 2 B B39 VHH 9844
337 2WZP 2 D, E, F, J, K, L CAMELID VHH5 9844
338 5LHQ 2 B Camelid-Derived Antibody Fragment Nb7 30538
339 1WT5 1 A, B ANTI EGFR ANTIBODY FV REGION VH fragment 9606
340 6EY0 2 E, G, H llama nanobody nb01 9844
341 6EY0 3 F llama nanobody nb01 9844
342 1JHL 2 H IGG1-KAPPA D11.15 FV (HEAVY CHAIN) 10090
343 5F9A 2 C Nanobody Nb-ER19 9844
344 4LLV 1 A, C, E, H 4E10 Fv heavy chain 9606
345 4LAR 1 H Single heavy chain variable fragment Heavy Chain 10090
346 5CBA 1 A, C 3b4 heavy chain 9606
347 5VXJ 2 B, D, F, H, J single-domain antibody JMK-E3 30538
348 1A14 2 H NC10 FV (HEAVY CHAIN) VH DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
349 1C08 2 B ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VH FRAGMENT 10090
350 2OTW 2 B, D Fv heavy chain variable domain VH 10090
351 3STB 1 A, B single domain antibody VHH 9844
352 2YSS 2 B ANTI-LYSOZYME ANTIBODY FV REGION VH FRAGMENT 9606
353 4W6W 2 B NbFedF6 9844
354 5JA8 2 B, D, F, H Nanobody 2 9844
355 2YBR 1 A, D, G SINGLE CHAIN ANTIBODY FRAGMENT 9004G HEAVY CHAIN, RESIDUES 1-117 9606
356 2BJM 1 H IGE SPE7 HEAVY CHAIN ANTHRONE ATTACHED HEAVY CHAIN, RESIDUES 1-120 10090
357 1P4B 2 H Antibody Variable heavy chain 10090
358 5U4M 2 B V1C7 VHH antibody 30538
359 5O0W 2 E, F, G, H Nb474 30538
360 4Y5V 1 A, D, G diabody 305 VH domain 9606
361 1DQL 2 H IGM MEZ IMMUNOGLOBULIN HEAVY CHAIN VARIABLE DOMAIN FRAGMENT 9606
362 1JTO 1 A, B Vh Single-Domain Antibody VH domain fragment 9838
363 3V0A 3 C Llama antibody F12 9844
364 5F97 2 E, F, G, H Nanbody Nb-ER19 9844
365 3K80 1 A, B Antibody 9844
366 5VAQ 2 B Nb914 Nanobody 9844
367 1QD0 1 A VHH-R2 ANTI-RR6 ANTIBODY VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
368 5F8Q 2 C, D Nanobody Nb-ER19 9844
369 4U05 1 A, B Single Domain Antibody 9844
370 5F9D 2 C Nanobody Nb-ER19 9844
371 4X4Y 1 A, C Human Variable Heavy Chain of Herceptin 9606
372 4LGP 2 B, D VHH1 camelid nanobody 30538
373 2P48 2 B ANTIBODY CAB-RN05 9838
374 5U4L 2 B V1C7 VHH antibody G29R variant 30538
375 5VXK 1 B single-domain antibody JMK-H2 30538
376 5F7M 2 C, D Nanobody Nb-ER19 9844
377 5DA4 1 A, B, C Nanobody recognizing the membrane protein SLC26Dg 9844
378 5F7W 2 C, D Nanobody Nb-ER19 9844
379 4YQX 1 H, N JES6-1 VH domain 10116
380 1EZV 10 X HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
381 3U6R 1 A, H Antibody 1:7 (Heavy chain) 9606
382 1NMC 2 B, H SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
383 1MEL 1 A, B VH SINGLE-DOMAIN ANTIBODY 9838
384 4NC1 2 C, D A20.1 VHH 9844
385 4NC1 3 E, F A26.8 VHH 9844
386 5M30 2 D, E, F Anti-vesicular stomatitis virus N VHH 30538
387 4WEU 1 D, E Anti-F4+ETEC bacteria VHH variable region 9844
388 2DQF 2 B, E Ig VH,anti-lysozyme 10090
389 5E7F 1 A, B, C nanobody L06 9838
390 2P46 2 B, D ANTIBODY CAB-RN05 9838
391 3CXH 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT 10090
392 5YOY 3 G, H, I, P, Q, R Golimumab heavy chain variable region 9606
393 5LWF 2 C, D Camelid heavy-chain antibody variable fragment cAb-G10S 9844
394 5LHP 2 B Camelid-Derived Antibody Fragment 30538
395 5USF 2 C, D Immunoglobulin heavy chain variable region 9844
396 1P84 10 J Heavy Chain (Vh) Of Fv-Fragment 10090
397 5SV4 1 A, B Single Domain Antibody A3C8 9844
398 4LGS 2 B Camelid nanobody (VHH4) 30538
399 3QXV 1 A, B, C, D, E Anti-Methotrexate CDR1-4 Graft VHH 9844
400 2XTJ 4 D FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-131 9606
401 5CBE 1 A, C E10 heavy chain 9606
402 2P47 2 B ANTIBODY CAB-RN05 9838
403 4KRM 2 B, D, F, H, J, L Nanobody/VHH domain 7D12 9844
404 3WXW 2 H V region heavy chain 10090
405 3K3Q 1 A llama Aa1 VHH domain 9844
406 4P2C 3 G, H, I, J, K Nanobody 1, Anti-F4+ETEC bacteria VHH variable region 9844
407 1AR1 3 C ANTIBODY FV FRAGMENT 10090
408 3EZJ 2 B, D, F, H NANOBODY NBGSPD_7 9844
409 5VNW 2 C, D Nb.b201 32630
410 1BVK 2 B, E HULYS11 FV 9606
411 6FE4 2 F, G, H, I, J Nb113 30538
412 5NML 1 A, B, C, D, E, F, G, H, I, J Nanobody Nb36 Ser85Cys 9844
413 2CJU 1 H NQ16-113.8 ANTI-PHOX ANTIBODY 10090
414 5HVF 2 B VHH-i83 30538
415 1P4I 2 H antibody variable heavy chain 10090
416 4PGJ 1 A, C Human heavy chain domain antibody 9606
417 4KDT 1 A, B Nanobody24 9835
418 3CFI 3 C, F, I, L Nanobody NBEPSIJ_11 9844
419 2VH5 1 H ANTI-RAS FV HEAVY CHAIN 9606
420 4S10 1 A, B GELSOLIN NANOBODY GELSOLIN NANOBODY 9844
421 5MJE 2 B Nanobody 8 9844
422 3LH2 2 H, I, J, K Fv 4E10 heavy chain 9606
423 3OGO 2 E, F, G, H GFP-nanobody 9838
424 4C59 2 B NANOBODY 9844
425 5VXL 2 B single-domain antibody JPS-G3 30538
426 1OAZ 2 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
427 4DK6 1 A, B single domain antibody VHH 9844
428 5F93 2 C, D, F, H Nanobody Nb-ER19 9844
429 5F7L 2 B, D Nanobody Nb-ER14 9844
430 1OAY 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
431 5HVG 2 B, D VHH-a204 30538
432 4LAQ 1 H Single heavy chain variable fragment Heavy chain 10090
433 3UPC 1 A, B, C, D, E, F, G, H, I, J heavy chain variable domain 9606
434 4W2Q 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
435 5HVH 2 B VHH-a204 30538
436 5HVH 3 C VHH-i83 30538
437 4XT1 3 C nanobody 7 30538
438 5LXG 2 H V REGION HEAVY CHAIN 10090
439 5HM1 1 A, B, C lama VHH antibody 2E7 9844
440 5FUC 3 E, V VHH6 9838
441 4RZC 1 A, C, E, H Fv M6P-1 light chain 9986
442 3H3P 1 H, I Fv 4E10 heavy chain 9606
443 5O2U 2 B, D VHH 59H10 9844
444 5SV3 1 A, C Anti-Ricin A-chain Single Domain Antibody (sdAb) A3C8 9844
445 3NN8 1 A, C, D, G Engineered scFv, heavy chain 10090
446 5OMN 2 C Nanobody (VHH) Nano-27 30538
447 4KRP 2 B Nanobody/VHH domain 9G8 9844
448 1OAX 1 H, J IMMUNOGLOBULIN E FV REGION, RESIDUES 1-122 10090
449 6FUZ 2 N nanobody 9839
450 4FHB 2 D Nb179 9844
451 4DK3 1 A, B single domain antibody VHH 9844
452 4KRL 1 B Nanobody/VHH domain 7D12 9844
453 4V1D 1 A SINGLE CHAIN ANTIBODY FRAGMENT LR, HEAVY CHAIN 9606
454 4V1D 4 D SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN 9606
455 1BZQ 2 K, L, M, N PROTEIN (ANTIBODY CAB-RN05) VARIABLE DOMAIN 9838
456 1NMA 3 H FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
457 1YZZ 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 9838
458 4LDE 2 B Camelid Antibody Fragment 9844
459 4Y5Y 1 A, D diabody 330 VH domain 9606
460 5DMJ 2 B, E, G 3H65-5 domain antibody (dAb) 9606
461 1BVL 1 A, C HULYS11 FV 10090
462 3RJQ 2 B Llama VHH A12 9844
463 1ZMY 1 A Antibody cabbcII-10:lys3 N-terminus, 142 residues 9838
464 3AB0 2 B, E antibody ScFv fragment, heavy chain 10090
465 3LHP 1 H, I Fv 4E10 heavy chain 9606
466 4N1H 2 B, D Camelid heavy-chain antibody variable fragment cAb-F11N 9844
467 6CK9 2 D 35O22 scFv heavy chain portion 9606
468 6EQI 2 B Nb696 9844
469 2BSE 2 D, E, F LLAMA IMMUNOGLOBULIN VHH RECOGNITION DOMAIN, RESIDUES 1-123 9844
470 1YC8 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33-hu 9838
471 4KFZ 2 C, D Anti-LMO2 VH 9606
472 2UUD 1 H, J NQ10-1.12 ANTI-PHOX ANTIBODY 10090
473 5TOJ 2 D, E, F Single-domain antibody F-VHH-4 9844
474 4Y5X 1 A, D, G, J diabody 310 VL domain 9606
475 4YGA 2 B, D, F, H VHH-1B7 30538
476 4UT9 2 H, I, J, K BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, HEAVY CHAIN DOMAIN 9606
477 2A9N 2 H, I fluorescein-scfv heavy chain 9606
478 5GS0 3 D, F heavy chain (anti-TLR3) 10090
479 5GS0 4 H, X heavy chain (anti-Lid) 10090
480 5G5X 2 B NANOBODY NB330, SELECTED FROM LLAMA, C-TERMINAL 6XHIS- TAG 9844
481 1KYO 10 J, U HEAVY CHAIN (VH) OF FV-FRAGMENT RESIDUES 1-127 10090
482 5GRJ 1 H avelumab H chain 9606
483 4NKD 1 A, C, E, G Engineered scFv heavy chain 10090
484 5BOZ 2 G, H, I, J, K, L VHH single chain antibody E1 30538
485 4KRO 2 B Nanobody/VHH domain EgA1 9844
486 3WXV 2 H V region heavy chain 10090
487 4KV5 2 E, G, H, J heavy chain GC1009 scFv 9606
488 3DWT 1 A, B, C, D, E, F, G, H cAbBCII-10 9838
489 5TJW 2 K NP-specific inhibitory VHH 30538
490 1QLE 5 H HEAVY CHAIN ANTIBODY FV FRAGMENT 10090
491 4LDL 2 B Camelid Antibody Fragment 9844
492 4LDO 2 B Camelid Antibody Fragment 9844
493 5XJ3 1 A, D, G, J ipilimumab-VH 9606
494 3SN6 5 N Camelid antibody VHH fragment 9844
495 5M94 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
496 4M8Q 1 A, H GEP1 Fv heavy chain 9606
497 5NHR 2 A, H Bimagrumab Fv heavy-chain VH 9606
498 4W2O 1 A, C, E, G Anti-Marburgvirus Nucleoprotein Single Domain Antibody B 9844
499 5O8F 2 K, O Nanobody Nb25 9844
500 5O8F 3 L, M, N Nanobody Nb25 9844
501 5NQW 2 C, D 026 9844
502 5C3L 4 D Nanobody Nb15 Nanobody 9838
503 5J3H 2 C mAb 83-7 Fab heavy chain 10090
504 5U8R 2 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
505 1G6V 2 K ANTIBODY HEAVY CHAIN CAB-CA05, VARIABLE DOMAIN 9838
506 5UK4 2 a, b, c, d, e, f, g, h, i, j, k, l, m, n, o, p, q, r, s, t Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition mofiv and HIS TAG 30538
507 5FV2 1 A, B, C VH DOMAIN ANTIBODY VH DOMAIN ANTIBODY 9606
508 4WGV 2 B, D Camelid antibody fragment, nanobody 9844
509 5OJM 2 K, L, M, N, O Nanobody Nb25 9844
510 6B73 2 C, D Nanobody 9844
511 4PIR 2 F, G, H, I, J VHH15 9844
512 5XWD 2 H VH chain of 059-152 9606
513 4QKX 2 B R9 protein 9844
514 5JQH 2 C, D Nanobody60, Nb60 9844
515 4YBQ 3 D, F antibody Fv fragment heavy chain 10090
516 4PD4 10 J Igh protein 10090
517 5DA0 2 B Nanobody 9844
518 4R0L 1 A, H Antibody 1C6 Heavy chain 10090
519 5U8Q 3 H Fv 24-60 heavy chain Heavy chain variable domain (residues 1-118) of mAb 24-60, including additional Gly-Thr at the N terminus and Glu-Asn-Leu-Tyr-Phe-Gln at C terminus. 10090
520 3P0G 2 B Camelid Antibody Fragment NANOBODY 9844
521 4ODX 2 A, H GEP7 Fv heavy chain 9606
522 5M95 2 B, D CAMELID ANTIBODY FRAGMENT, NANOBODY 9844
523 4WGW 2 B, D Camelid antibody fragment, nanobody 9844
524 1RVF 6 H FAB 17-IA 10090
525 5JZ7 2 C, G, H, J MEDI578 scFv, heavy chain 9606
526 5IHL 2 B, E, G, I 3H56-5 domain antibody (dAb) 3H56-5 dAb 9606
527 4MQS 2 B Nanobody 9-8 9844
528 5DHY 1 A, H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
529 1QFW 4 H ANTIBODY (ANTI ALPHA SUBUNIT) (HEAVY CHAIN) FV 10090
530 1QFW 6 I ANTIBODY (ANTI BETA SUBUNIT) (HEAVY CHAIN) FV 10090
531 3K81 2 A, B Single strand antibody VHH domain single domain antibody VHH 9844
532 4OGA 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
533 4MQT 2 B Nanobody 9-8 9844
534 5TOK 2 D, E, F Single-domain antibody F-VHH-L66 9844
535 4NKM 1 A, C, E, G Engineered scFv heavy chain 10090
536 3W11 3 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
537 4NKO 2 B, D, F Engineered scFv heavy chain 10090
538 5EUL 4 V AYC08 30538
539 5GXB 2 B nanobody 30538
540 5NBD 2 C Nanobody 9844
541 3W13 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
542 3W12 2 C monoclonal antibody fab 83-7 fragment - heavy chain 10090
543 5H8O 1 A VHH nanobody 9844
544 4KSD 2 B R2 protein 9844
545 5DHZ 1 H Anti-Rev Antibody Fab single-chain variable fragment, heavy chain 9986
546 2A0L 3 D, F 33H1 Fv fragment Fv fragment, heavy chain 10090
547 5DFZ 4 E Nanobody binding S. cerevisiae Vps34 9844
548 5UKB 1 a, b, c, d, e Anti-vesicular stomatitis virus N VHH GGLPETGGHHHHHH Sortase A recognition motif and HIS tag. 30538
549 5WDU 2 D, O, W bnAb NIH45-46 scFv heavy chain 9606
550 5TD8 5 E nanobody 30538
551 6CDI 4 5, M, m PGT122 Heavy Chain 9606
552 6BSP 1 A U4 Heavy chain 10090
553 6B3J 6 N Nanobody 35 9844
554 6EHG 3 C hC3Nb1 9844
555 5Y0A 2 D, F, H variable region of Fab ZKA190 heavy chain 9606
556 5XS7 2 H Heavy chain of Fab 1D5 10090
557 5W3L 5 E C5 antibody variable heavy domain 10090
558 5W3M 1 E C5 antibody variable heavy domain 10090
559 5W3O 1 D C5 antibody variable heavy domain 10090
560 5W3E 1 E C5 antibody variable heavy domain 10090
561 5VAI 6 N nanobody 35 9844
562 5UZ7 4 N NANOBODY 35 9844
563 5TSJ 10 1, 2 Human heavy chain domain antibody 9606
564 5TR1 2 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
565 5TQQ 3 H, I Monoclonal antibody, Fab fragment, heavy chain 10090
566 5H32 2 G, I, K C10 IgG heavy chain variable region 9606
567 5H37 3 G, I, K C10 IgG heavy chain variable region 9606
568 5H30 3 G, I, K IgG C10 heavy chain 9606
569 5KWL 4 7 VHH 10E 9838
570 5KTZ 4 7 VHH 12B 9838
571 5KU0 4 7 VHH 17B 9838
572 5KU2 4 7 VHH 7A 9838
573 5KEL 3 H, P, Q c2G4 variable Fab domain heavy chain 9606
574 5KEL 5 C, J, M c13C6 variable Fab domain heavy chain 9606
575 5KEM 2 B, G BDBV91 variable Fab domain heavy chain 9606
576 5KEM 3 D, I c13C6 variable Fab domain heavy chain 9606
577 5KEN 3 C, G, N c4G7 variable Fab domain heavy chain 9606
578 5KEN 6 J, Q c13C6 variable Fab domain heavy chain 9606
579 3JCX 2 H Fab E heavy chain 10116
580 5FOJ 1 A NANOBODY 9838
581 3JBC 5 7 nanobody VHH PVSP29F 9838
582 3JBD 5 7 nanobody VHH PVSP6A 9838
583 3JBE 5 7 nanobody VHH PVSS8A 9838
584 3JBF 5 7 nanobody VHH PVSP19B 9838
585 3JBG 5 7 nanobody VHH PVSS21E 9838
586 3JBA 2 H H16.U4 antibody heavy chain Fab variable domain 10090
587 3JAU 2 H Heavy chain of Fab fragment variable region of antibody D5 10090
588 5A1Z 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
589 4UIF 3 G, I, K ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - HEAVY CHAIN 9606
590 4UIH 2 D, F ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -HEAVY CHAIN 9606
591 4UDF 4 11, 15, 19, 1D, 1H, 1L, 1P, 1T, 1X, 21, 25, 29, 2D, 2H, 2L, 2P, 2T, 2X, 31, 35, 39, 3D, 3H, 3L, 3P, 3T, 3X, 41, 45, 49, 4D, 4H, 4L, 4P, 4T, 4X, 51, 55, 59, 5D, 5H, 5L, 5P, 5T, 5X, 61, 65, 69, 6D, 6H, 6L, 6P, 6T, 6X, 7D, 7H, 7L, 7P, 7T, 7X HUMAN MONOCLONAL ANTIBODY 9606
592 3J8Z 3 F, G, H, I H16.1A heavy chain variable domain Fab 10090
593 3J8V 3 F, G, H, I H16.14J heavy chain variable domain Fab 10090
594 3J8W 2 F, G, H, I H263.A2 heavy chain variable domain Fab 10090
595 3J7E 2 B, D, F, H H16.V5 Fab heavy chain variable domain 10090
596 3J6U 3 H Fab 5J7 heavy chain variable region 9606
597 4CKD 2 H, I, J, K SCFV13R4 ANTIBODY FV HEAVY CHAIN 10090
598 3IY1 2 B Fab B, heavy chain 10116
599 3IY2 2 B Antibody 6, heavy chain FRAGMENT OF ANTIBODY 6 10090
600 3IY3 2 B antibody fragment from neutralizing antibody 8 (heavy chain) 10090
601 3IY4 2 B fragment of neutralizing antibody 15 (heavy chain) 10090
602 3IY5 2 B antibody fragment IGG2A (heavy chain) 10090
603 3IY6 2 B fragment from neutralizing antibody E (heavy chain) 10116
604 3IY7 2 B fragment from neutralizing antibody F (heavy chain) 10116
605 3IY0 2 H Fab 14, heavy domain 10090
606 1IEH 1 A BRUC.D4.4 SINGLE DOMAIN ANTIBODY FROM A NAIVE LLAMA LIBRARY 9844
607 1G9E 1 A H14 9844
608 1QNZ 1 H 0.5B ANTIBODY (HEAVY CHAIN) FV 10090
609 1VHP 1 A VH-P8 9606